Guggenheim Maintains Buy on Gentex, Raises Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Ronald Jewsikow has maintained a Buy rating on Gentex (NASDAQ:GNTX) and increased the price target from $40 to $41.

April 17, 2024 | 5:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst Ronald Jewsikow reaffirmed a Buy rating on Gentex and raised the price target to $41 from $40.
The upgrade in price target by a reputable analyst like Ronald Jewsikow suggests a positive outlook on Gentex's stock, likely due to strong fundamentals or growth prospects. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100